10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

The stock market rally stalled on Tuesday, with the S&P 500 Index retreating from its record closing high of 6,001.35. The weakness could be due to traders taking profit off their recent gains and shifting to the sidelines ahead of some key Main Street data on inflation and retail sales.

IT, real-estate and industrial stocks served as drags, while the strength in the consumer discretionary and financial spaces offset some of the weakness.

As the market pauses, here’s a compilation of stocks retailers on the Stocktwits platform are most bullish and bearish about:

Most Bullish

Neuronetics, Inc. ($STIM)

Pennsylvania-based Neuronetics, a commercial-stage med-tech company has seen its shares plunge hard following its third-quarter earnings announcement. The loss per share of $0.44 grossly missed the consensus loss estimate of $0.23, and revenue of $18.53 million also trailed the $19.14 million.

The stock plunged about 40% but retail is ‘extremely” bullish on the stock.

Zscaler, Inc. ($ZS)

Shares of Zscaler, a San Jose, California-based cybersecurity company, rose nearly 3% on Tuesday following an announcement regarding its “Zero Trust Segmentation” solution. 

This solution will “provide a more secure, agile and cost-effective means to connect users, devices, and workloads across and within globally distributed branches, factories, campuses, data centers, and public clouds,” the company said.

Axsome Therapeutics, Inc. ($AXSM)

New York-based Axsome, which focuses on central nervous system disorders, reported a double beat for the third quarter. The stock rose over 6% following the quarterly results. The company has an FDA decision date in late January for its migraine treatment candidate. 

“We expect a busy end to the year with several clinical catalysts anticipated, including a planned simultaneous release of topline results from the ongoing Phase 3 ADVANCE-2 and ACCORD-2 trials of AXS-05 in Alzheimer’s disease agitation in the fourth quarter,” said CEO Herriot Tabuteau.

Bitcoin Depot, Inc. ($BTM)

Atlanta, Georgia-based Bitcoin Depot provides users with simple and efficient ways to convert cash into Bitcoin ($BTC.X). 

The company’s shares are pulling back after Monday’s 54% jump but retail held on to its bullish bias.

MediciNova, Inc. ($MNOV)

La Jolla, California-based MediciNova, said it was notified by Sanofi ($SNY) that the Sanofi/Novartis AG ($NVS) litigation was settled. This provides for MediciNova receiving a certain amount of monetary damages through this settlement. MediciNova’s stock jumped following the news, triggering positive reaction from the retail crowd.

Most Bearish

Reviva Pharmaceuticals, Holdings, Inc. ($RVPH)

Reviva, a late-stage pharma developing therapies in the areas of central nervous system, inflammatory and cardiometabolic diseases, announced a positive update on the enrollment for the ongoing 1-year open-label extension study evaluating the long-term safety and tolerability of brilaroxazine in patients with schizophrenia. The stock climbed about 33% on Tuesday but retail sentiment was at a rock bottom.

Pagaya Technologies Ltd. ($PGY)

Israel-based Pagaya, a provider of financial products and services, reported a loss for the third quarter, which was much wider than expected. The stock slumped over 35%. Some among the retailers called outt the company a “fraud.

Aldeyra Therapeutics, Inc. ($ALDX)

Lexington, Massachusetts-based Aldeyra is a biotech focusing on therapies for immune-mediated and metabolic diseases. The shares of the company plunged on Tuesday on just about average volume. 

Retailers on the Stocktwits platform fretted over poor data for its dry eye disease product candidate. 

Quantum-Si Inc. ($QSI)

Protein sequencing company Quantum-Si’s shares plunged over 22% on Tuesday after the  Branford, Connecticut-based company reported its third-quarter results.

ViaSat, Inc. ($VSAT)

Shares of Carlsbad, California-based ViaSat have been ailing ever since the satellite telecommunications reported its financial results for the fiscal year 2025 second-quarter results last Thursday. This, in turn, has dented retail sentiment. 

Read Next: Tesla Stock’s Post-Election Rally Stalls But Analyst Talks Up His $500 Bull-Case Scenario: Retail Mood Stays Sou

For updates and corrections email newsroom@stocktwits.com